Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Q32 Bio Inc. | 4,354,484 | reported | 22 Dec 2020 | tx 4−1,025,900 |
| Thimble Point Acquisition Corp. | 0 | reported | 10 Apr 2023 | tx 3−16,544,113 |
| scPharmaceuticals Inc. | 0 | reported | 21 Nov 2017 | tx 10+3,253,437−18,659,012 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 10 Apr 2023 | SALE | Thimble Point Acquisition Corp. | 12,836,489 | 0.12 USD | |
| 10 Apr 2023 | SALE | Thimble Point Acquisition Corp. | 3,172,769 | 0.12 USD | |
| 10 Apr 2023 | SALE | Thimble Point Acquisition Corp. | 534,855 | 0.12 USD | |
| 22 Dec 2020 | SALE | Q32 Bio Inc. | 480,000 | 12.82 USD | |
| 22 Dec 2020 | SALE | Q32 Bio Inc. | 20,000 | 12.82 USD | |
| 16 Nov 2018 | SALE | Q32 Bio Inc. | 21,036 | 20.20 USD | |
| 16 Nov 2018 | SALE | Q32 Bio Inc. | 504,864 | 20.20 USD | |
| 21 Nov 2017 | CONVERSION | scPharmaceuticals Inc. | 1,011,623 | — | |
| 21 Nov 2017 | PURCHASE | scPharmaceuticals Inc. | 628,572 | 14.00 USD | |
| 21 Nov 2017 | CONVERSION | scPharmaceuticals Inc. | 42,150 | — | |
| 21 Nov 2017 | PURCHASE | scPharmaceuticals Inc. | 26,190 | 14.00 USD | |
| 21 Nov 2017 | CONVERSION | scPharmaceuticals Inc. | 1,483,107 | — | |
| 21 Nov 2017 | CONVERSION | scPharmaceuticals Inc. | 61,795 | — | |
| 21 Nov 2017 | CONVERSION | scPharmaceuticals Inc. | 302,652 | 0.00 USD | deriv |
| 21 Nov 2017 | CONVERSION | scPharmaceuticals Inc. | 443,708 | 0.00 USD | deriv |
| 21 Nov 2017 | CONVERSION | scPharmaceuticals Inc. | 10,649,003 | 0.00 USD | deriv |
| 21 Nov 2017 | CONVERSION | scPharmaceuticals Inc. | 7,263,649 | 0.00 USD | deriv |